INFUSYSTEM HOLDINGS, INC Total Assets
INFUSYSTEM HOLDINGS, INC (INFU) had Total Assets of $97.70 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-04
- 2026-06-30: Assets $97.70M.
- 2026-03-31: Assets $98.66M.
- 2025-12-31: Assets $100.56M.
- 2025-09-30: Assets $98.88M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $97.70M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $98.66M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $100.56M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $98.88M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $100.85M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $104.28M 10-Q · filed 2026-05-08 | |
| 2024-12-31 | $103.61M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $105.30M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $108.53M 10-Q · filed 2025-08-05 | |
| 2024-03-31 | $104.85M 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $102.92M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $102.07M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $102.75M 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $102.26M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $99.39M 10-K · filed 2024-04-10 | |
| 2022-09-30 | $98.98M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $98.82M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $98.24M 10-Q · filed 2023-05-09 | |
| 2021-12-31 | $97.59M 10-K · filed 2024-04-10 | |
| 2021-09-30 | $94.79M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $96.00M 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $90.59M 10-Q · filed 2022-05-05 | |
| 2020-12-31 | $96.99M 10-K · filed 2023-03-16 | |
| 2020-09-30 | $80.31M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $83.97M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $82.68M 10-Q · filed 2021-05-10 | |
| 2019-12-31 | $79.22M 10-K · filed 2022-03-15 | |
| 2019-09-30 | $77.89M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $72.36M 10-Q · filed 2020-08-14 | |
| 2019-03-31 | $67.25M 10-Q · filed 2020-05-15 | |
| 2018-12-31 | $64.07M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $63.99M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $63.52M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $64.97M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $68.88M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $85.33M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $88.71M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $91.89M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $96.34M 10-K · filed 2018-03-19 | |
| 2016-09-30 | $97.09M 10-Q · filed 2016-12-12 | |
| 2016-06-30 | $98.28M 10-Q/A · filed 2016-12-12 | $100.27M 10-Q · filed 2016-08-10 |
| 2016-03-31 | $98.75M 10-Q/A · filed 2016-12-12 | $100.16M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $95.36M 10-K · filed 2017-03-22 | $96.45M 10-K · filed 2016-03-09 |
| 2015-09-30 | $93.30M 10-K/A · filed 2016-12-12 | $93.78M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $91.53M 10-K/A · filed 2016-12-12 | $91.78M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $87.36M 10-K/A · filed 2016-12-12 | $87.47M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $80.21M 10-K/A · filed 2016-12-12 | |
| 2014-09-30 | $81.02M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $77.73M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $78.25M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $77.37M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $76.39M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $75.75M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $76.23M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $77.52M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $74.02M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $74.72M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $75.63M 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $76.26M 10-K · filed 2013-03-28 | |
| 2011-09-30 | $79.49M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $93.56M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $130.36M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |